ASH 2023 Myeloma Recap with Ben Derman, MD

By Blood Cancer Talks - Last Updated: January 10, 2024

In the latest episode of Blood Cancer Talks, Ben Derman, MD, of the University of Chicago Medicine, joins hosts Raj Chakraborty, MD; Ashwin Kishtagari, MD; and Edward Cliff, MD; for a myeloma recap from the 2023 American Society of Hematology (ASH) Annual Meeting and Exposition.

Dr. Derman and the hosts highlighted the Perseus trial in newly diagnosed transplant-eligible myeloma; the ISKIA trial that compared isatuximab, carfilzomib, lenalidomide, and dexamethasone (isa-KRd) versus KRd; long-term follow-up data from the GMMG relapse trial; overall survival results of the KarMMa-3 trial; and more.

This podcast originally appeared on Blood Cancer Talks. 

Advertisement
Advertisement
Advertisement
Editorial Board